Journal articleAsia Pac J Clin Oncol2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.
- Journal
- Asia Pac J Clin Oncol
- Published
- 22 June 2018
- Citations
- 6
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- BackgroundA Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Cl… NCT02670746↗
- BackgroundTreatment of Pancreatic Cancer With Abraxane NCT02555813↗
- BackgroundNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (t… NCT01964430↗